Literature DB >> 12581879

Triiodothyronine is a survival factor for developing oligodendrocytes.

Sidney A Jones1, Dawn M Jolson, Kristin K Cuta, Cary N Mariash, Grant W Anderson.   

Abstract

Thyroid hormone plays an important role in oligodendrocyte development. The studies presented here suggest that thyroid hormone is required for oligodendrocyte survival during development. Oligodendrocyte precursor cells, astrocytes and microglia were cultured in a defined media. Oligodendrocyte precursor cell differentiation was induced by growth factor removal. Time course studies revealed that oligodendrocytes cultured in the presence or absence of triiodothyronine (T3) develop similarly during the first 3 days of development. Oligodendrocytes cultured in the absence of T3, however, die after developmental day 3. TdT-Mediated dUDP Nick End Labeling assay and Hoechst staining indicate that T3 rescues developing oligodendrocytes from death by apoptosis. Apoptosis is likely induced by the presence of the cytokines TNFalpha and IL-1beta. However, expression of these cytokines is not altered by thyroid hormone administration. Thus, thyroid hormone has been demonstrated to effect proliferation, myelin gene expression and now the survival of developing oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12581879     DOI: 10.1016/s0303-7207(02)00296-4

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  27 in total

1.  Distinctive properties of human adult brain-derived myelin progenitor cells.

Authors:  Francesca Ruffini; Nathalie Arbour; Manon Blain; André Olivier; Jack P Antel
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 2.  Thyroid hormone and cerebellar development.

Authors:  Grant W Anderson
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

3.  Treatment with thyroxine restores myelination and clinical recovery after intraventricular hemorrhage.

Authors:  Linnea R Vose; Govindaiah Vinukonda; Sungro Jo; Omid Miry; Daniel Diamond; Ritesh Korumilli; Arslan Arshad; Muhammad T K Zia; Furong Hu; Robert J Kayton; Edmund F La Gamma; Rashmi Bansal; Antonio C Bianco; Praveen Ballabh
Journal:  J Neurosci       Date:  2013-10-30       Impact factor: 6.167

4.  Developmental iodine deficiency resulting in hypothyroidism reduces hippocampal ERK1/2 and CREB in lactational and adolescent rats.

Authors:  Jing Dong; Wanyang Liu; Yi Wang; Yi Hou; Qi Xi; Jie Chen
Journal:  BMC Neurosci       Date:  2009-12-18       Impact factor: 3.288

Review 5.  Glial development: the crossroads of regeneration and repair in the CNS.

Authors:  Vittorio Gallo; Benjamin Deneen
Journal:  Neuron       Date:  2014-07-16       Impact factor: 17.173

6.  The balance between oligodendrocyte and astrocyte production in major white matter tracts is linearly related to serum total thyroxine.

Authors:  David S Sharlin; Daniel Tighe; Mary E Gilbert; R Thomas Zoeller
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

Review 7.  Expression of thyroid hormone receptor isoforms in the oligodendrocyte lineage.

Authors:  Louis L Sarliève; Angeles Rodríguez-Peña; Keith Langley
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

8.  Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging.

Authors:  Laura-Adela Harsan; Jérôme Steibel; Anita Zaremba; Arnaud Agin; Rémy Sapin; Patrick Poulet; Blandine Guignard; Nathalie Parizel; Daniel Grucker; Nelly Boehm; Robert H Miller; M Said Ghandour
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

Review 9.  Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis.

Authors:  Jane M Rodgers; Andrew P Robinson; Stephen D Miller
Journal:  Discov Med       Date:  2013-08       Impact factor: 2.970

10.  Mice lacking thyroid hormone receptor Beta show enhanced apoptosis and delayed liver commitment for proliferation after partial hepatectomy.

Authors:  Raquel López-Fontal; Miriam Zeini; Paqui G Través; Mariana Gómez-Ferrería; Ana Aranda; Guillermo T Sáez; Concha Cerdá; Paloma Martín-Sanz; Sonsoles Hortelano; Lisardo Boscá
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.